Strategies to combat Tay-Sachs disease - ScienceDirect

Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS - The Lancet Child & Adolescent Health

Screening for Carriers of Tay-Sachs Disease among Ashkenazi Jews — A Comparison of DNA-Based and Enzyme-Based Tests

Tay-Sachs disease in Jacob sheep - ScienceDirect

Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment - Genetics in Medicine

PDF) The first family with Tay-Sachs disease in Cyprus: Genetic analysis reveals a nonsense (c.78G>A) and a silent (c.1305C>T) mutation and allows preimplantation genetic diagnosis

PDF] Tay-Sachs Disease: Mechanisms of Neuropathology and Potential Therapeutic Strategies Utilizing Human Lysosomal Sialidase

Structural consequences of amino acid substitutions causing Tay–Sachs disease - ScienceDirect

Tay-Sachs disease in Jacob sheep - ScienceDirect

Lysosomal storage disorders: from biology to the clinic with reference to India - The Lancet Regional Health - Southeast Asia

Frontiers New Approaches to Tay-Sachs Disease Therapy

Natural history of Tay-Sachs disease in sheep - ScienceDirect

PDF) An Inducible Mouse Model of Late Onset Tay–Sachs Disease

Progranulinopathy: A Diverse Realm of Disorders Linked to Progranulin Imbalances - ScienceDirect

Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity: Molecular Therapy

Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease - ScienceDirect